Phase IV Study in Asthma Subjects for Dry Powder Inhaler (DPI) Versus (vs) Metered Dose Inhaler (MDI) Correct Use

Condition:   Asthma
Interventions:   Device: ELLIPTA DPI;   Device: GSK MDI;   Device: AZ MDI
Sponsor:   GlaxoSmithKline
Not yet recruiting – verified June 2016

View full post on ClinicalTrials.gov: asthma | received in the last 14 days

Leave a Reply

Your email address will not be published. Required fields are marked *